Cytolytic Attack Against Lung Parenchyma in Emphysema

肺气肿中对肺实质的细胞溶解攻击

基本信息

  • 批准号:
    6621326
  • 负责人:
  • 金额:
    $ 12.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-01-01 至 2006-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many asymptomatic HIV-infected individuals develop alveolitis followed by emphysema but the pathogenesis remains unknown. We have found that cytotoxic lymphocytes (CTLs) are elevated in the airway of subjects that develop emphysema and that these patients have substantial morphologic evidence of parenchymal tissue loss. This corroborates other studies demonstrating that CTL elevation coincides with an early decline in diffusion capacity and an increase in lower airway epithelial permeability. A key observation is that CTLs isolated from the lung of HIV-infected subjects can accomplish MHC class 1 restricted killing of HIV infected cells. The focus of this investigation is to expand on a series of ground-breaking discoveries made by the applicant that reveal the following, 1) 141V infects human lung epithelial cells in vivo and in vitro; 2) the lung epithelium is permissive to HIV replication; and 3) that HIV infection of lung epithelial cells induces CTL-mediated apoptosis in an MHC restricted manner. Specific Aim 1 will test the hypothesis that primary human lung epithelial cells are infected by HIV-1 from the apical and basolateral surface and permit viral replication following cell (NF-0) activation. We predict that this will result in the release of competent free virus. Specific Aim 2 will test the hypothesis that HIV infection of primary human lung epithelial cells triggers a CTL-mediated assault resulting in epithelial cell apoptosis. In this pursuit we will identify the mechanism by which epithelial cell apoptosis occurs and then determine if a potent epithelial cell mitogen, keratinocyte growth factor, can prevent lung epithelial cell death. In the revised application we will develop a physiologically relevant model for studies with HIV. In particular, primary human lung epithelial cells will be grown on collagen coated trans-well inserts to establish fully differentiated monolayers with tight junctions at an air-liquid interface. The model will be used to identify preferential HIV transport which we believe is highly relevant since the epithelium may serve as a portal for HIV entry into the lung (basolateral to apical) as well as reintroduce virus back into the circulation (apical to basolateral). Subsequent studies will utilize the same model to identify how autologous, HIV-specific, CTLs dispose of the HIV+ lung epithelial cell. The long-term goal of the applicant is to establish a career in translational research that connects his current expertise in clinical medicine with basic science. The candidate has made a substantial commitment to pursue a career that will explore the lung parenchymal response to inflammation and translate discoveries into useful solutions for patients with lung disease. The applicant has established an excellent group of advisors to assist in this endeavor and has secured the appropriate institutional support to complete the training.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAREN Lee KNOELL其他文献

DAREN Lee KNOELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAREN Lee KNOELL', 18)}}的其他基金

Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia
锌稳态缺陷会损害宿主对肺炎球菌肺炎的防御能力
  • 批准号:
    10543428
  • 财政年份:
    2021
  • 资助金额:
    $ 12.69万
  • 项目类别:
Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia
锌稳态缺陷会损害宿主对肺炎球菌肺炎的防御能力
  • 批准号:
    10365619
  • 财政年份:
    2021
  • 资助金额:
    $ 12.69万
  • 项目类别:
Role of ZIP8 in secondary cigarette smoke exposure-mediated lung injury
ZIP8 在继发性香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    9397646
  • 财政年份:
    2016
  • 资助金额:
    $ 12.69万
  • 项目类别:
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
ZIP8 在第一手香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    8787779
  • 财政年份:
    2014
  • 资助金额:
    $ 12.69万
  • 项目类别:
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
ZIP8 在第一手香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    8986202
  • 财政年份:
    2014
  • 资助金额:
    $ 12.69万
  • 项目类别:
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
ZIP8 在第一手香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    8630038
  • 财政年份:
    2014
  • 资助金额:
    $ 12.69万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    8044007
  • 财政年份:
    2007
  • 资助金额:
    $ 12.69万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    7393145
  • 财政年份:
    2007
  • 资助金额:
    $ 12.69万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    7266785
  • 财政年份:
    2007
  • 资助金额:
    $ 12.69万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    7588768
  • 财政年份:
    2007
  • 资助金额:
    $ 12.69万
  • 项目类别:

相似海外基金

Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
  • 批准号:
    486527
  • 财政年份:
    2022
  • 资助金额:
    $ 12.69万
  • 项目类别:
    Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
  • 批准号:
    nhmrc : GNT1164054
  • 财政年份:
    2020
  • 资助金额:
    $ 12.69万
  • 项目类别:
    Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8996707
  • 财政年份:
    2014
  • 资助金额:
    $ 12.69万
  • 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
  • 批准号:
    8880646
  • 财政年份:
    2014
  • 资助金额:
    $ 12.69万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    9206412
  • 财政年份:
    2014
  • 资助金额:
    $ 12.69万
  • 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
  • 批准号:
    8723605
  • 财政年份:
    2014
  • 资助金额:
    $ 12.69万
  • 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    8072956
  • 财政年份:
    2010
  • 资助金额:
    $ 12.69万
  • 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
  • 批准号:
    105348415
  • 财政年份:
    2009
  • 资助金额:
    $ 12.69万
  • 项目类别:
    Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
  • 批准号:
    5354871
  • 财政年份:
    2002
  • 资助金额:
    $ 12.69万
  • 项目类别:
    Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
  • 批准号:
    7991835
  • 财政年份:
    2001
  • 资助金额:
    $ 12.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了